Exelixis

Natera

Corcept Therapeutics

Intra-Cellular Therapies

ACADIA Pharma

Incyte

Catalyst Pharmaceuticals

Gilead Sciences

Neurocrine Biosciences

United Therapeutics

First Trust NYSE Arca Biotechnology Index Fund

FBT tracks an equal-weighted index of US biotechnology stocks.

Fidelity MSCI Information Technology Index ETF

iShares Nasdaq Biotechnology ETF

iShares U.S. Home Construction ETF

iShares U.S. Technology ETF

Invesco Dynamic Building & Construction ETF

Vanguard Information Technology ETF

SPDR S&P Biotech ETF

SPDR S&P Homebuilders ETF

Technology Select Sector SPDR Fund

Here we highlight three sectors that are sizzling with investing opportunities as the second wave of the outbreak is gathering steam.

3 Hot Sector ETFs to Tide Over the Coronavirus Crisis in Q3

ARK Genomic Revolution Multi-Sector ETF

VanEck Vectors Biotech ETF

As the coronavirus outbreak continues to aggravate, investors are eyeing developments in vaccine or treatments to combat the pandemic.

Biotech ETFs to Gain as Coronavirus Vaccine Hopes Strengthen

In the continuing quest to find a vaccine for the coronavirus, the World Health Organization announced Wednesday it is dropping hydroxychloroquine, the malaria drug backed by President Trump, who claims it has helped him, from its global study that examines potential treatments for Covid-19. The WHO decided to terminate the trial following another separate trial that [.

Biotech ETFs Still Promising Despite Hydroxychloroquine Trial

While the Coronavirus pandemic continues dominating healthcare sector headlines, investors shouldn’t fret that biotechnology ETFs will be left vulnerable when the virus is finally vanquished. That’s good news for the First Trust NYSE Arca Biotechnology Index Fund (NYSEArca: FBT), among other biotech ETFs.

There’s Still Plenty of Opportunity for Biotech Post-Coronavirus

ALPS Equal Sector Weight ETF

iShares MSCI USA Equal Weighted ETF

Amplify Online Retail ETF

Invesco S&P 500 Equal Weight ETF

Virtus Real Asset Income ETF

SPDR NYSE Technology ETF

The S&P 500’s top five stocks account for 19.8% of the index’s total weight. These seven index funds avoid getting top-heavy.

7 Equal-Weighted Index Funds to Buy for 2020 and Beyond 

Here we take a look at how the latest updates on drugs, antibody therapies and vaccines targeted at winning the coronavirus battle can affect biotech ETFs.

How Are Biotech ETFs Reacting to Coronavirus Treatment News?

Novavax's latest progress in the Covid-19 vaccine development brings optimism to the Wall Street.

Biotech ETFs Soaring on COVID-19 Vaccine Progress

Loncar Cancer Immunotherapy ETF

iShares Genomics Immunology and Healthcare ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare Providers ETF

Invesco Dynamic Biotechnology & Genome ETF

Invesco DWA Healthcare Momentum ETF

ALPS Medical Breakthroughs ETF

SPDR S&P Health Care Services ETF

SPDR S&P Pharmaceuticals ETF

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners

Invesco Dynamic Pharmaceuticals ETF

Health Care Select Sector SPDR Fund

Coronavirus Sparked Healthcare ETFs In General, But Ultimately, We Really Do Need To Pick And Choose

iShares North American Tech-Software ETF

Invesco NASDAQ Internet ETF

First Trust NASDAQ-100 Technology Sector Index Fund

iShares PHLX Semiconductor ETF

We have presented a bunch of five top-performing ETFs of the 11-year bull market that will continue to outperform in the coming months given that these have a solid Zacks Rank.

Bull Market Turns 11: 5 ETF Winners

First Trust Dow Jones Internet Index Fund

First Trust Health Care AlphaDEX Fund

Vanguard Consumer Discretionary ETF

Consumer Discretionary Select Sector SPDR Fund

These sector ETFs emerged winners in the 11-year old bull market and may survive despite the coronavirus scare.

4 Sector ETF Winners of Bull Market Look Resilient to Virus

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their Q4 earnings releases.

Can Biotech ETFs Gain on Mixed Q4 Earnings Results?

Companies in the biotech industry face an incredible amount of risk while getting their drugs to market.

The Top Biotech ETFs to Watch in 2020

ARK Web x.0 ETF

Fidelity MSCI Consumer Staples ETF

Invesco KBW High Dividend Yield Financial ETF

VanEck Mortgage REIT Income ETF

iShares MSCI Global Metals & Mining Producers ETF

Invesco S&P SmallCap Utilities & Communication Services ETF

Schwab U.S. REIT ETF

How To Avoid The Worst Sector ETFs: Q4 2019

iShares MSCI Emerging Markets ETF

iShares Global Clean Energy ETF

Aberdeen Standard Physical Palladium Shares ETF 

PowerShares Cleantech Portfolio

First Trust NASDAQ Clean Edge Green Energy Index Fund

Schwab Emerging Markets Equity ETF

Invesco Solar ETF

Vanguard FTSE Emerging Markets ETF

As ETF investing constantly climbs the popularity charts, we highlight a few good ETF areas that investors can bank on for 2020.

Top ETF Areas for 2020

Virtus LifeSci Biotech Products ETF

Principal Healthcare Innovators Index ETF

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

A Guide to Biotech ETF Investing

CRISPR Therapeutics

Global Blood Therapeutics

Novartis

Vertex Pharmaceuticals

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to drive the biotech market.

Why Biotech ETFs Surged in Monday's Trading Session

While the rest of the biotechnology sector remained depressed along with the broader markets, related exchange traded funds found strength from an unexpected surge in ACADIA Pharmaceuticals (NasdaqGS: ACAD), following the biopharma company’s positive announcement for a phase 3 trail on dementia-related psychosis.

ACADIA Pharmaceuticals Help Lift Biotech ETFs

iShares U.S. Aerospace & Defense ETF

The U.S. economy has stepped into the 11th year of the expansion, exhibiting the longest expansion in history. These winning ETFs and stocks will rally further.

ETF Winners of Longest US Economic Expansion

Amgen

Biogen

Bristol-Myers

Celgene

Direxion Daily S&P Biotech Bull 3X Shares

Regeneron Pharmaceuticals

When the stock market is hitting record highs, it’s important to remember that it’s really a market of stocks rather than a stock market. Not all companies are created equal. Nor are all sectors.

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

iShares U.S. Healthcare ETF

Vanguard Health Care ETF

M&A activity, approval of novel drugs and earnings growth in Q1 put healthcare ETFs in a decent spot.

Health Day Checkup of Medical ETFs: 5 Top Picks

News for First Trust NYSE Arca Biotechnology Index Fund ETF (FBT)